Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock · CUSIP: 252828108
Event date: 2026-09-30
- Filing-level shares
- 2,846,786
- Percent of class
- 5.08%
- Vanguard Capital Management
Shares: 2,846,786 · Class: 5.08%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002100119-26-001565
- Form type
- SCHEDULE 13G
- Filer
- VANGUARD CAPITAL MANAGEMENT LLC
- CIK
- CIK 2100119
- Filed
- Oct 30, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership